Comparison of Dosimetry (mGy/MBq) of Ligands Used to Study Dopamine System
| Organ | [18F]FECNT | [11C]Raclopride* | [123I]FP-CIT† |
|---|---|---|---|
| Gallbladder wall | 1.70 × 10−2 | 6.1 × 10−2 | 2.57 × 10−2 |
| Bladder wall | 1.70 × 10−2 | 1.7 × 10−2 | 2.57 × 10−2 |
| Liver | 1.03 × 10−2 | 3.2 × 10−2 | 2.85 × 10−2 |
| Small intestine | 1.81 × 10−2 | 1.6 × 10−2 | 2.07 × 10−2 |
| Kidney | 1.43 × 10−2 | 9.0 × 10−3 | 1.12 × 10−2 |
| Lungs | 1.24 × 10−2 | 4.25 × 10−2 | |
| Basal ganglia | 9.78 × 10−2 | 2.3 × 10−1 | |
| Effective dose | 1.75 × 10−2 | 2.44 × 10−2 | |
| Equivalent | |||
| (mSv/MBq) | |||
| (mSv/MBq) | 1.58 × 10−2 | 1.0 × 10−2 | 2.38 × 10−2 |